Chemkart India Ltd — Important, 18-05-2026: Company Update

Chemkart India Ltd. released its H2 FY26 Investor Presentation, highlighting a consolidated revenue of INR 214.83 Cr for FY26 with 7.1% volume growth. Half-year revenue for H2 FY26 rose 23.8% to INR 111.60 Cr, with EBITDA at INR 14.02 Cr (up 10.9%) and PAT at INR 9.50 Cr (up 6.8%). The company is making steady progress on its greenfield nutraceutical CDMO facility in the JNPT SEZ, aimed at enhancing manufacturing capabilities for export markets. This strategic expansion and a robust order book of INR 65.26 Cr position Chemkart to capitalize on India's expanding nutraceutical industry.